Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Long-Term Investments (2021 - 2025)

Precision Biosciences (DTIL) has disclosed Long-Term Investments for 5 consecutive years, with $744000.0 as the latest value for Q4 2025.

  • Quarterly Long-Term Investments fell 76.79% to $744000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $744000.0 through Dec 2025, down 76.79% year-over-year, with the annual reading at $744000.0 for FY2025, 76.79% down from the prior year.
  • Long-Term Investments for Q4 2025 was $744000.0 at Precision Biosciences, roughly flat from $744000.0 in the prior quarter.
  • The five-year high for Long-Term Investments was $3.2 million in Q4 2023, with the low at $744000.0 in Q2 2025.
  • Average Long-Term Investments over 5 years is $2.4 million, with a median of $3.1 million recorded in 2021.
  • The sharpest move saw Long-Term Investments soared 280.67% in 2022, then tumbled 76.79% in 2025.
  • Over 5 years, Long-Term Investments stood at $3.1 million in 2021, then dropped by 16.66% to $2.6 million in 2022, then rose by 24.46% to $3.2 million in 2023, then changed by 0.0% to $3.2 million in 2024, then crashed by 76.79% to $744000.0 in 2025.
  • According to Business Quant data, Long-Term Investments over the past three periods came in at $744000.0, $744000.0, and $744000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.